GDRX
GoodRxANasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
The post-earnings bull case is that Q1 was better than feared: revenue beat available consensus in secondary coverage, FY2026 guidance was raised, Pharma Direct grew 82%, subscriptions grew 16%, and third-party market coverage described a positive immediate stock reaction after the print.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite.
What can break
Balance-sheet flexibility is adequate but not wide open, with $235.7 million of cash against $493.8 million of total outstanding debt as of March 31, 2026 [#8-K-2026-05-06].
Momentum
82
Value
68
Sentiment
39
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $2.80 · Bull $3.35 · Bear $2.10
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $2.88
Why
Momentum82 · Δ7d -
Value68 · Δ7d -1.1
Sentiment39 · Δ7d -
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
82
34% active weight
Current posture
7d trendSoftening
Δ7d
-
Δ21d
-
Value
68
32% active weight
Current posture
7d trendSoftening
Δ7d
-1.1
Δ21d
-0.7
Sentiment
39
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade A. Momentum 81.9 / Value 68.2 / Sentiment 39.4
Fundamentals (TTM)As of 2026-06-01
Fundamentals (TTM)
As of 2026-06-01
Market Cap
$1.04B
Beta
1.50
Shares Out
339.43M
P/E (TTM)
33.0
P/S (TTM)
1.20
P/FCF (TTM)
9.16
Rev YoY
+0.4%
EPS YoY
-68.5%
Gross Margin
+93.5%
Op Margin
+10.4%
Net Debt
$43.37M
Current Ratio
3.11
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology